Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Petrie

Showing results (21-30 of 476) with videos related to

Pageof 48
Sort By:
European Heart Journal|March 13, 2012
Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failureDavide Castagno, Mark C Petrie, Brian Claggett, et al.
Journal of the American College of Cardiology|October 29, 2025
Who Benefits From a Primary Prevention ICD?Daniel J Doherty, Mark C Petrie, Roy S Gardner
European Heart Journal|December 28, 2020
EMPEROR-REDUCED reigns while EMPERIAL whimpersMark C Petrie, Matthew M Lee, Ninian N Lang
European Journal of Heart Failure|January 9, 2021
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversyDaniela Tomasoni, Mark C Petrie, Marianna Adamo, et al.
Heart (British Cardiac Society)|January 13, 2021
Coronary revascularisation in patients with ischaemic cardiomyopathyMatthew Ryan, Holly Morgan, Mark C Petrie, et al.
Journal of the American College of Cardiology|November 12, 2025
What Is Heart Failure With Preserved Ejection Fraction?Mark C Petrie, Kieran F Docherty, John J McMurray
The New England Journal of Medicine|December 20, 2023
Semaglutide and Heart Failure with Preserved Ejection Fraction and Obesity. ReplyMikhail N Kosiborod, Barry A Borlaug, Mark C Petrie
Circulation|September 3, 2024
Response by Kosiborod et al to Letter Regarding Article, "Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial"Mikhail N Kosiborod, Mark C Petrie, Barry A Borlaug
The New England Journal of Medicine|July 24, 2024
Semaglutide, Obesity-Related Heart Failure, and Type 2 Diabetes. ReplyMikhail N Kosiborod, Mark C Petrie, Barry A Borlaug
Circulation|January 30, 2013
Letter by MacDonald et al regarding article, "Catheter ablation of atrial fibrillation"Michael R MacDonald, John J V McMurray, Mark C Petrie
Pageof 48

Showing results (21-30 of 476) with videos related to

Sort By:
Pageof 48
European Heart Journal|March 13, 2012
Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failureDavide Castagno, Mark C Petrie, Brian Claggett, et al.
Journal of the American College of Cardiology|October 29, 2025
Who Benefits From a Primary Prevention ICD?Daniel J Doherty, Mark C Petrie, Roy S Gardner
European Heart Journal|December 28, 2020
EMPEROR-REDUCED reigns while EMPERIAL whimpersMark C Petrie, Matthew M Lee, Ninian N Lang
European Journal of Heart Failure|January 9, 2021
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversyDaniela Tomasoni, Mark C Petrie, Marianna Adamo, et al.
Heart (British Cardiac Society)|January 13, 2021
Coronary revascularisation in patients with ischaemic cardiomyopathyMatthew Ryan, Holly Morgan, Mark C Petrie, et al.
Journal of the American College of Cardiology|November 12, 2025
What Is Heart Failure With Preserved Ejection Fraction?Mark C Petrie, Kieran F Docherty, John J McMurray
The New England Journal of Medicine|December 20, 2023
Semaglutide and Heart Failure with Preserved Ejection Fraction and Obesity. ReplyMikhail N Kosiborod, Barry A Borlaug, Mark C Petrie
Circulation|September 3, 2024
Response by Kosiborod et al to Letter Regarding Article, "Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial"Mikhail N Kosiborod, Mark C Petrie, Barry A Borlaug
The New England Journal of Medicine|July 24, 2024
Semaglutide, Obesity-Related Heart Failure, and Type 2 Diabetes. ReplyMikhail N Kosiborod, Mark C Petrie, Barry A Borlaug
Circulation|January 30, 2013
Letter by MacDonald et al regarding article, "Catheter ablation of atrial fibrillation"Michael R MacDonald, John J V McMurray, Mark C Petrie
Pageof 48